Letter: increased incidence of tissue transglutaminase antibody in Israel-is it always related to coeliac disease? Authors' reply

Aliment Pharmacol Ther. 2021 May;53(9):1053-1054. doi: 10.1111/apt.16343.

Authors

Amir Ben Tov^{1

2

3}, Gabriel Chodick^{1

2}, Shlomi Cohen^{1

3}, Niva Lechtman^{1

2}, Raanan Shamir⁴

Affiliations

¹ Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.
² Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Pediatric Gastroenterology Unit, Dana-Dwek Children's Hospital, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
⁴ Institute of Pediatric Gastroenterology, Nutrition, and Liver Diseases, Schneider Children's Medical Center, Petach Tikva, Israel.

PMID: 33831239
DOI: 10.1111/apt.16343

No abstract available

Publication types

Letter
Comment

MeSH terms

Autoimmunity
Celiac Disease* / diagnosis
Celiac Disease* / epidemiology
GTP-Binding Proteins
Humans
Incidence
Israel / epidemiology
Protein Glutamine gamma Glutamyltransferase 2
Transglutaminases

Substances

Protein Glutamine gamma Glutamyltransferase 2
Transglutaminases
GTP-Binding Proteins